Abstract
Traumatic brain injury (TBI) is becoming increasingly recognised as a major cause of disability, with a significant impact on health costs both in the developed and developing world. At present, there is no effective treatment for this type of acute neurological injury. Docosahexaenoic acid (DHA) is an abundant polyunsaturated fatty acid in the brain, known to have a significant structural role as well as functional roles. Preclinical accumulating evidence indicates that DHA has potential as a restorative therapeutic agent for traumatic brain injury.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
